Goldman Sachs’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$393K Buy
+13,163
New +$325K ﹤0.01% 5870
2025
Q2
– Sell
-1,105
Closed -$13.8K – 6086
2025
Q1
$13.8K Sell
1,105
-4,797
-81% -$92.1K ﹤0.01% 5959
2024
Q4
$181K Buy
+5,902
New +$174K ﹤0.01% 5671
2024
Q2
– Sell
-1,377
Closed -$39.4K – 5655
2024
Q1
$39.4K Buy
+1,377
New +$47.1K ﹤0.01% 5336
2022
Q3
– Sell
-543
Closed -$18K – 6260
2022
Q2
$18K Buy
+543
New +$17.7K ﹤0.01% 6192
2021
Q3
– Sell
-777
Closed -$205K – 6229
2021
Q2
$205K Buy
777
+193
+33% +$60.7K ﹤0.01% 5728
2021
Q1
$237K Sell
584
-316
-35% -$141K ﹤0.01% 5562
2020
Q4
$363K Buy
+900
New +$280K ﹤0.01% 4791

Other funds holding BDSX

Goldman Sachs's BDSX Position: Q3 2026 in Review

Goldman Sachs opened a new position in Biodesix (BDSX) in Q3 2026: 13,163 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #5870 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in BDSX as recently as Q1 2025.

Goldman Sachs first reported a position in BDSX in Q4 2020 and has held it in 8 quarters since. 61 funds tracked by Wall St. Rank hold BDSX as of Q3 2026.

  • Goldman Sachs held 13,163 shares of Biodesix worth $393K as of Q3 2026.
  • Biodesix was a new Goldman Sachs position in Q3 2026.
  • Biodesix made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5870 holding.
  • Goldman Sachs first reported a position in Biodesix in Q4 2020 and has held it in 8 quarters since.
  • 61 funds tracked by Wall St. Rank held Biodesix as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.